摘要
随着中医药事业的发展,中药在国内外的使用越来越广泛,但是伴随而来的是缺乏安全性证据、自身制作工艺欠成熟、医务人员对毒性认识不足、公众误区等问题的日益严重,尤其对于心血管病患者,因此,需要我们心血管病科医师提高对中药制剂及其作用、副作用的认识,并且要监督及鉴别中药-西药的相互作用,同时要求科研工作者通过严格的实验设计评估中药的安全性和有效性,进一步提高中药的质量、安全性和有效性,严格制定产品说明规范,宣教引导临床医师和普通大众对中药的合理使用。
Along with the development of Chinese medicine and pharmacy （CMP）, Chinese materia medica （CMM） has been used more and more widely at home and abroad. But we have to confront worsening problems such as lack of safety evidence, immature self -formulation technologies, lack of knowledge about their toxicities, and public misunderstanding, especially for patients with cardiovascular disease （CVD）. Therefore, we cardiovascular physicians are requested improve knowledge for CMM preparations and their effects and side effects, supervise and identify the interactions between CMM and Western medicine. Meanwhile, the researchers are also requested to assess the safety and efficacy of CMM through rigorous experimental designs, further im- prove the quality, safety, and efficacy of CMM, strictly formulate the specification of CMM products, guide the ra- tional use of CMM by clinicians and the general public.
出处
《中国中西医结合杂志》
CAS
CSCD
北大核心
2012年第7期994-998,共5页
Chinese Journal of Integrated Traditional and Western Medicine
基金
广州市科技计划项目(中药新药通冠胶囊的临床前研究)(No.2010U1-E00531-10)
关键词
心血管病
中药
安全性
cardiovascular disease
Chinese materia medica
safety
